Changelog
Posts in category "Release"
Posts are organized into categories for ease of navigation:
- Algorithm - developments to the interpretation algorithm implemented in Python.
- Announcement - general news related to the Molecular Oncology Almanac.
- Annual newsletters - annual newsletters that recap updates.
- Database - changes and additions to the underlying knowledge base.
- Release - aggregated release notes from GitHub releases (serving as the project changelog).
-
Database release
This Release contains updates to the draft version of the database. Concept mappings to RxNorm, SNOMED, and OMOP are now present for all curated therapies. We additionally curate an approval for imlunestrant from the European Medicines Agency, as well as another for belzutifan from both the European Medicines Agency and Food and Drug Administration.
Continue reading -
Database release
This release contains updates to the draft version of the database. EGFR TKD activating variants was introduced as a biomarker and associated with regulatory approvals from the European Medicines Agency (EMA) and Health Canada (HC). No additional genomic knowledge statements were added with this release, though several were modified.
Continue reading -
Database release
This release contains updates to the draft version of the database with FDA precision oncology approvals from February 2026. Specifically, indications and derived relationships were updated for Braftovi (encorafenib), Hernexeos (zongertinib), and Keytruda (pembrolizumab).
Continue reading -
Database release
This release contains updates to the draft version of the database with FDA precision oncology approvals for Akeega. Additionally, the Organizations table was merged into the Agents table.
Continue reading -
Database release
This release contains updates to the current and draft versions of the database with FDA precision oncology approvals from October, November, and December 2025.
Continue reading -
Algorithm release 0.8.5
This release utilizes the v.2025-02-07 version of the MOAlmanac database. Cancer Gene Census is also no longer required to run moalmanac. The interpreter version was increased to 0.8.5.
Continue reading -
Algorithm release 0.8.4
This release utilizes the v.2025-02-07 version of the MOAlmanac database. Both COSMIC and ExAC are now no longer required to run moalmanac. The interpreter version was increased to 0.8.4.
Continue reading -
Database release
This release contains updates to the current and draft versions of the database with FDA and EMA precision oncology approvals from September 2025.
Continue reading -
Algorithm release 0.8.3
This release utilizes the v.2025-02-07 version of the MOAlmanac database. It includes a fix to a bug that prevented HTML report generation. Specifically, in rare circumstances, the columns
Continue readingsensitive_score_bin_map,resistance_score_bin_map, andprognostic_score_bin_mapwere not added to the data object for actionable variants, which are used to sort report tables. -
Database release
This release contains updates to the current and draft versions of the database with FDA oncology approvals from June, July, and August 2025. The change log local to this repository has been removed and pointers now direct to news.moalmanac.org. Release notes will also continue to be available through this repository’s Releases.
Continue reading -
Algorithm release 0.8.2
This release utilizes the v.2025-02-07 release of the underlying MOAlmanac database. The codebase now supports Python 3.13 with no warnings produced, although we will continue officially using 3.12 for the time being.
Continue reading -
Database release
Updated current and draft version of the database with FDA oncology approvals from May and June, thus far, 2025.
Continue reading -
Database release
Updated current and draft version of the database with FDA oncology approvals from April 2025.
Continue reading -
Database release
In this release, we have normalized
Continue readingtherapy_namevalues to NCI thesaurus (#40) and merged an initial version of the next version of our database (#36), that aims to follow with GA4GH’s Genomic Knowledge Standards for the database schema (Read more here). -
Database release
Added entries:
Continue reading -
Algorithm release 0.8.1
This release utilizes version 2025-02-07 of the underlying moalmanac database and contains changes from several pull requests: #32, #33, #35, and #36.
Continue reading -
Database release
This database release contains relevant FDA Oncology updates from March 2025.
Continue reading -
Algorithm release 0.8.0
This release utilizes the v.2024-12-05 version of the underlying database and contains changes from several pull requests: #27, #28, #29, #30, #31.
Continue reading -
Database release
This release contains 1,001 approved relationships.
Continue reading -
Database release
This release contains 997 approved relationships.
Continue reading -
Algorithm release 0.7.2
This release utilizes the v.2024-10-03 release of the underlying MOAlmanac database and otherwise fixes two bugs present in Release 0.7.1. This release incorporates pull requests https://github.com/vanallenlab/moalmanac/pull/23 and https://github.com/vanallenlab/moalmanac/pull/24.
Continue reading -
Database release
This release contains 993 approved relationships.
Continue reading -
Algorithm release 0.7.1
This release utilizes the v.2024-04-11 release of the underlying MOAlmanac database and primarily focuses on adding logging to MOAlmanac and refactoring the codebase to remove the
Continue readingdatasources/directory from the application folder. It incorporates changes from two pull requests: https://github.com/vanallenlab/moalmanac/pull/21 and https://github.com/vanallenlab/moalmanac/pull/22. -
Database release
This release contains 989 approved relationships.
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Algorithm release 0.6.0
This release utilizes the v.2024-04-11 release of the underlying MOAlmanac database and primarily focuses on supporting Python 3.12. It incorporates changes from two pull requests: https://github.com/vanallenlab/moalmanac/pull/18 and https://github.com/vanallenlab/moalmanac/pull/19.
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Algorithm release 0.5.0
This release utilizes the v.2023-11-09 release of the underlying MOAlmanac database and incorporates changes from three pull requests: #15: Added AIP to hereditary cancers gene list, #16: Update db nov 2023, and #17: Revise handling of COSMIC mutational signatures.
Continue reading -
Database release
Added entries:
Continue reading -
Database release
This month’s data release features recent FDA approvals, updates of mutational signatures from version 2 to 3.4, updates to the source fields for several citations, removal of several entries, revising format of all clinical guideline citations, and the
Continue readingpublication_datefield has been populated for all current database records. -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Algorithm release 0.4.6
This release utilizes the v.2023-04-06 release of the underlying MOAlmanac database. It incorporates changes from two pull requests: #13 and #14.
Continue reading -
Database release
Added entries:
Continue reading -
Algorithm release 0.4.5
This release utilizes the v.2023-02-02 release of the underlying MOAlmanac database. It incorporates changes from three pull requests: changing the underlying MOAlmanac database from TinyDB to JSON (#9), adding a simplified input option to run MOAlmanac (#10), and updating datasources (#11).
Continue reading -
Database release
In this release, we add two recent precision oncology approvals from the FDA regarding ER signaling inhibition in two cancer types.
Continue reading -
Database release
In this release, we add two recent precision oncology approvals from the FDA.
Continue reading -
Database release
In this release, we have removed neoantigen burden as a cataloged feature type and combined Silencing with Knockdown feature types. We additionally expanded upon fields required for each feature type within our S.O.P.
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Revised entries:
Continue reading -
Database release
Revised entries:
Continue reading -
Algorithm release 0.4.2
This release utilizes the v.2021-02-04 release of the underlying MOAlmanac database.
Continue reading -
Database release
Added entries:
Continue reading -
Database release
Added entries:
Continue reading -
Database release
The following assertions sourced from recent FDA approvals were added to the Molecular Oncology Almanac in this release -
Continue reading -
Database release
The following recent FDA approvals were added to the Molecular Oncology Almanac in this release -
Continue reading -
Database release
The following changes were made to the Molecular Oncology Almanac in this release -
Continue reading -
Algorithm release 0.4.1
This release utilizes the v.2021-02-04 release of the underlying MOAlmanac database.
Continue reading -
Database release
In addition to the content changes listed below, this release added a therapeutic strategy (
Continue readingtherapy_strategy) for all sensitive and resistance relationships. -
Database release
Added entries:
Continue reading -
Database release
This release focuses on FDA approvals since March 2020. In addition to the following changes, the citation style for all FDA approved associated have been updated to match American Medical Association (AMA) style formatting.
Continue reading